Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis.

Literature DB >> 27930413

Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis.

Jessica Philpott¹, Jean Ashburn, Bo Shen.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2017 PMID： 27930413 DOI： 10.1097/MIB.0000000000000992

Source DB: PubMed Journal: Inflamm Bowel Dis ISSN： 1078-0998 Impact factor: 5.325

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Successful treatment of chronic refractory pouchitis with vedolizumab.

Authors: Fazia Mir; Mohamad Hasan Yousef; Edward Kenneth Partyka; Veysel Tahan
Journal: Int J Colorectal Dis Date: 2017-07-11 Impact factor: 2.571

2. Refractory Chronic Pouchitis and Autoimmune Hemolytic Anemia Successfully Treated with Vedolizumab.

Authors: Diana Martins; Paula Ministro; Américo Silva
Journal: GE Port J Gastroenterol Date: 2018-02-14

3. Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.

Authors: Bram Verstockt; Charlotte Claeys; Gert De Hertogh; Gert Van Assche; Albert Wolthuis; André D'Hoore; Séverine Vermeire; Marc Ferrante
Journal: United European Gastroenterol J Date: 2019-08-20 Impact factor: 4.623

4. Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.

Authors: Martin Gregory; Kimberly N Weaver; Patrick Hoversten; Stephen Bradley Hicks; Devin Patel; Matthew A Ciorba; Alexandra M Gutierrez; Poonam Beniwal-Patel; Sowmya Palam; Gaurav Syal; Hans H Herfarth; George Christophi; Laura Raffals; Edward L Barnes; Parakkal Deepak
Journal: Inflamm Bowel Dis Date: 2019-08-20 Impact factor: 5.325

Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis.

1. Successful treatment of chronic refractory pouchitis with vedolizumab.

2. Refractory Chronic Pouchitis and Autoimmune Hemolytic Anemia Successfully Treated with Vedolizumab.

3. Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.

4. Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.

5. Use of vedolizumab in a patient with chronic and refractory pouchitis.

Review 6. Outcomes and Management of the Ileal Pouch-Anal Anastomosis in the Elderly.

7. Vedolizumab for chronic antibiotic-refractory pouchitis.

Review 8. Medical treatment of pouchitis: a guide for the clinician.

Review 9. A Personalized Approach to Managing Patients With an Ileal Pouch-Anal Anastomosis.

Review 10. Chronic Antibiotic-Refractory Pouchitis: Management Challenges.